Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Assessing Sartorius (XTRA:SRT3) Valuation As High P/E Contrasts With Discounted Cash Flow Estimate
Bio-Rad (BIO) Q1 2026: Non-GAAP EPS $1.89 (miss vs $2.81), Revenue $592.1M (beat vs $588. ...
Is It Time To Reassess Sartorius (XTRA:SRT3) After Its Multi Year Share Price Slide
Sartorius AG (SSSGY) Q1 2026 Earnings Call Highlights: Strong Start with Robust Sales Growth ...
Sartorius Stedim Biotechf: A Pure-Play Bet on Biopharma Industry Recovery | Morningstar
Sartorius Well Positioned to Benefit From Biopharma Industry Recovery | Morningstar
Sartorius Aktiengesellschaft Q1 Earnings Call Highlights - Stock Observer
Sartorius Aktiengesellschaft (SARTF) Reports Q1 Earnings with Positive Outlook
Sartorius (SARTF) Projected to Post Quarterly Earnings on Thursday - Daily Political
Sartorius (SARTF) Expected to Announce Quarterly Earnings on Thursday
New CellCelector CLD takes you from thousands of candidates to the top clone, faster
Latest news
Show moreRussia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict
Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions
Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis
